Carotenuto, Antonio
Valsasina, Paola
Hidalgo de la Cruz, Milagros http://orcid.org/0000-0002-7574-2143
Cacciaguerra, Laura
Preziosa, Paolo http://orcid.org/0000-0002-7826-0019
Marchesi, Olga
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Rocca, Maria A. http://orcid.org/0000-0003-2358-4320
Article History
Received: 8 July 2021
Revised: 17 November 2021
Accepted: 23 November 2021
First Online: 7 January 2022
Competing interests
: AC has received research grants from the ECTRIMS-MAGNIMS and from Almirall, and served on advisory boards for: Merk, Novartis, Roche and Almirall. PV received speaker honoraria from Biogen Idec. MHdlC reports no disclosures. LC received speaker and consultant honoraria from ACCMED, Roche, BMS Celgene, and Sanofi. PP received speaker honoraria from Biogen, Novartis, Merck Serono, Bristol Myers Squibb and Genzyme. He is supported by a senior research fellowship FISM – Fondazione Italiana Sclerosi Multipla – cod. 2019/BS/009 and financed or co-financed with the ‘5 per mille’ public funding. OM reports no disclosures. MF is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, Associate editor of <i>Radiology</i>, and Associate Editor of <i>Neurological Sciences</i>; received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA). MAR received speaker honoraria from Bayer, Biogen, Bristol Myers Squibb, Celgene, Genzyme, Merck Serono, Novartis, Roche, and Teva, and receives research support from the MS Society of Canada and Fondazione Italiana Sclerosi Multipla.